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Process ranging studies require screening numerous variables like seed density, temperature, dissolved 
oxygen, pH, raw material variability, etc. Due to the large number of variables that need to be studied as well as 
the interactions between them, it is prudent to use automated and high throughput bioreactor systems such as 
the ambr® 250 combined with Multivariate Data Analysis (MVDA) to monitor and analyze batches. The 
suitability of such methodology for determining process performance at not only standard conditions but also for 
excursions of variables at extreme values was evaluated.   A fractional factorial design with four process 
parameters (pH, temperature, dissolved oxygen and seeding density) and using a CHO cell line expressing an 
IgG, was performed and compared in both 2-L glass bioreactors and an ambr® 250  system with 24 single-use 
vessels.  Responses like peak viable cell density, viability and titer followed very similar trends in the 2-L and the 
ambr® 250 bioreactors.  However, some quality attributes like charge variants were different between the two 
systems.  MVDA analysis was performed using both online and offline post batch analysis with SIMCA software.  
It demonstrated that the process performance of 2-L and ambr® 250 for most variables were highly similar.  
Also, MVDA helped elucidate the potential sources for discrepancies between the AMBR and 2-L bioreactors 
quality attributes.    
  
